Pfizer's 'brainstorming' payment deals as gene therapies advance, exec tells Bloomberg

Pfizer’s ‘brainstorming’ payment deals as gene therapies advance, exec tells Bloomberg
Gene therapies offer a “world of wonders” for patients, but they present some scientific and manufacturing challenges, a top Pfizer exec told Bloomberg. And with some 10,000 of the pricey therapies in development, pharma companies and payers need to get outcomes-based payments nailed down.
Source: Fierce Pharma
Pfizer’s ‘brainstorming’ payment deals as gene therapies advance, exec tells Bloomberg